Coventry University Featured PhD Programmes
University of Edinburgh Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
University of Dundee Featured PhD Programmes
Cardiff University Featured PhD Programmes
"action" AND "research"×
10 miles

Pharmacy / Pharmaceutics (action research) PhD Projects, Programs & Scholarships

We have 9 Pharmacy / Pharmaceutics (action research) PhD Projects, Programs & Scholarships

  • "action" AND "research" ×
  • Pharmacy / Pharmaceutics×
  • clear all
Order by 
Showing 1 to 9 of 9
  Identification of novel glucose-dependent alterations responsible for vascular dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr R Sturmey
Application Deadline: 31 March 2020

Funding Type

PhD Type

Diabetes is a growing global healthcare problem. The majority of people living with diabetes have Type 2 diabetes mellitus (T2DM), characterised by a resistance of the body to the action of insulin.
  Investigating the mechanism of action of dual antiangiogenic/ antineoplastic drugs using organotypic co-culture of fibroblasts and endothelial cells
  Research Group: Institute of Cancer Therapeutics
  Dr J Elies Gomez, Dr K Pors
Applications accepted all year round

Funding Type

PhD Type

An important feature of many types of cancer is the ability to develop abnormal angiogenesis (blood vessel formation); this allows cancer cells to gain access to nutrients and favours metastasis.
  MRC DTP 4 Year PhD Programme: Bacterial stress sensing and antibiotic action
  Dr U Zachariae, Dr M Bergkessel
Application Deadline: 11 January 2020

Funding Type

PhD Type

This project is offered as part of the University of Dundee 4-year MRC DTP Programme “Quantitative and Interdisciplinary approaches to biomedical science”.
  Cationic antimicrobial peptides as anticancer agents
  Dr R Green, Prof R A Frazier
Applications accepted all year round

Funding Type

PhD Type

Cationic peptides are widespread in nature where they play a key role in host defense within plants and animals. The mechanism by which these peptides interact with cell membranes potentially leads to these being less prone to antimicrobial resistance than conventional antibiotics.
  High-throughput discovery of novel antibiotics using synthetic microbiology
  Dr R Draheim
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance (AMR) is a frequent problem in the treatment of disease caused by several clinical bacterial pathogens. In the European Union, antibiotic-resistant infections kill nearly 25,000 patients and represent a total expenditure of £1.5 billion per year.
  Design and synthesis of novel, targeted, anti-cancer agents
  Prof H Osborn, Dr F Greco
Applications accepted all year round

Funding Type

PhD Type

One of the major problems of cancer chemotherapy is that the drugs used have poor selectivities for cancer cells and cause damage to normal cells and organs.
  Impact of Inflammatory Signals on the Regenerative, Anti-inflammatory and Immunomodulatory Potential of Human Mesenchymal Stem Cells and their Secretome
  Dr D Widera
Applications accepted all year round

Funding Type

PhD Type

Adult multipotent stem cells can be easily isolated from a variety of adult human tissues and organs including bone marrow and adipose tissue.
  Catching BAM in the act: a strategy for novel antibiotics?
  Research Group: BBSRC White Rose DTP
  Dr D Brockwell, Prof S E Radford, Prof N A Ranson
Application Deadline: 6 January 2020

Funding Type

PhD Type

Gram negative bacteria are important pathogens to both humans and livestock responsible for life-threatening opportunistic systemic hospital infections, respiratory and urinary tract infections and gastric ulcers.
  The molecular mechanisms underpinning individual variation in platelet function and their effect on the progression and treatment of cardiovascular disease.
  Dr CI Jones
Applications accepted all year round

Funding Type

PhD Type

Platelets are small blood cells that play a vital role in the chronic and acute progression of Cardiovascular Disease (CVD). Platelets respond to a range of agonists, which are released when blood vessels are damaged, by aggregating together to form thrombi.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.